QR kȏd

Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.

<h4>Background</h4>The presence of tumor-specific mutations in the cancer genome represents a potential opportunity for pharmacologic intervention to therapeutic benefit. Unfortunately, many classes of oncoproteins (e.g., transcription factors) are not amenable to conventional small-molecule screeni...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Kimberly Stegmaier, Jenny S Wong, Kenneth N Ross, Kwan T Chow, David Peck, Renee D Wright, Stephen L Lessnick, Andrew L Kung, Todd R Golub
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science (PLoS) 2007-04-01
Serija:PLoS Medicine
Online pristup:https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.0040122&type=printable
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!